Page last updated: 2024-08-23

paclitaxel and Microsatellite Instability

paclitaxel has been researched along with Microsatellite Instability in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Demes, M; Eichler, K; Jeroch, J; Martin, D; Pession, U; Schulze, F; Waidmann, O; Wild, P1
Auranen, A; Black, D; Boere, I; Buscema, J; Chase, DM; Cibula, D; Coleman, RL; Copeland, LJ; dePont Christensen, R; Gilbert, L; Gill, SE; Gold, MA; Hanker, LC; He, Z; Herzog, TJ; Landrum, LM; McCourt, C; Mirza, MR; Monk, BJ; Novák, Z; Pothuri, B; Powell, MA; Raspagliesi, F; Shahin, MS; Sharma, S; Slomovitz, BM; Stevens, S; Stuckey, A; Tian, M; Valabrega, G; Zografos, E1
Mano, M; Masuda, N; Masuyama, M; Mizutani, M; Mori, K; Morikawa, N; Otani, Y; Yasojima, H1
Ackroyd, SA; Huang, ES; Kurnit, KC; Lee, NK1
Berlin, J; Cardin, D; Das, S1
Ishibashi, T; Ishikawa, M; Ishikawa, N; Kurioka, H; Kyo, S; Minamoto, T; Nakamura, K; Nakayama, K; Nakayama, S; Ono, R; Onuma, H; Otsuki, Y; Razia, S; Yamashita, H1

Reviews

1 review(s) available for paclitaxel and Microsatellite Instability

ArticleYear
Harnessing the Immune System in Pancreatic Cancer.
    Current treatment options in oncology, 2018, 08-20, Volume: 19, Issue:10

    Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Immunotherapy; Irinotecan; Leucovorin; Microsatellite Instability; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms

2018

Trials

1 trial(s) available for paclitaxel and Microsatellite Instability

ArticleYear
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
    The New England journal of medicine, 2023, 06-08, Volume: 388, Issue:23

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; DNA Mismatch Repair; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplasm Recurrence, Local; Paclitaxel

2023

Other Studies

4 other study(ies) available for paclitaxel and Microsatellite Instability

ArticleYear
Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and
    Oncotarget, 2022, Volume: 13

    Topics: Anus Neoplasms; Carboplatin; HIV Infections; Humans; Microsatellite Instability; Mutation; MutL Protein Homolog 1; Nivolumab; Paclitaxel; Papillomavirus Infections; Programmed Cell Death 1 Receptor

2022
Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case report.
    Immunotherapy, 2021, Volume: 13, Issue:3

    Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Drug Resistance, Neoplasm; Female; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Microsatellite Instability; Middle Aged; Paclitaxel; Retreatment; Treatment Outcome; Triple Negative Breast Neoplasms

2021
Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis.
    Gynecologic oncology, 2021, Volume: 162, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Decision Trees; Drug Costs; Endometrial Neoplasms; Female; Humans; Markov Chains; Microsatellite Instability; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Phenylurea Compounds; Progression-Free Survival; Quality of Life; Quality-Adjusted Life Years; Quinolines

2021
Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies).
    International journal of molecular sciences, 2019, Jul-31, Volume: 20, Issue:15

    Topics: Aged; Antibodies, Neutralizing; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma; Carcinoma, Endometrioid; Cisplatin; DNA Mismatch Repair; Doxorubicin; Endometrial Neoplasms; Female; Gene Expression; Humans; Immunophenotyping; Lymphocytes, Tumor-Infiltrating; Microsatellite Instability; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Programmed Cell Death 1 Receptor

2019